The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
本发明涉及
三环化合物及其制药组合物,它们是一种或多种FGFR酶的
抑制剂,并且在治疗与FGFR相关的疾病,如癌症方面有用。